CHG-2023-0150

Formulation Change for Mavacamtamex. Facility Change for Mavacamtamex — routine update. Impacts 4 markets and 2 variations.

Change Number
CHG-2023-0150
Type
Formulation Change
Product
Mavacamtamex
Status
Failed
Owner
Tomoko Ikeda
Initiated
2022-12-06
Description

Facility Change for Mavacamtamex — routine update

Impacted Markets (4)
JP — JapanBR — BrazilNL — NetherlandsRU — Russia
Impacted Modules
2.3.P4.2.13.2.P3.2.S
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved